Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomy

Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic... World J Urol (2017) 35:1191–1197 DOI 10.1007/s00345-016-1979-z ORIGINAL ARTICLE Improved decision making in intermediate‑risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomy 1,3 2,3 3 1,3 Jean Baptiste Beauval · Guillaume Ploussard · Bastien Cabarrou · Mathieu Roumiguié · 4 1 6 4 5 5 Adil Ouzzane · Jérome Gas · Annabelle Goujon · Gautier Marcq · Romain Mathieu · Sébastien Vincendeau · 6 7 8 1,3 9 Xavier Cathelineau · Pierre Mongiat‑Artus · Laurent Salomon · Michel Soulié · Arnaud Méjean · 8 10 6 Alexandre de La Taille · Morgan Rouprêt · François Rozet · Committee of Cancerology of the Association of French Urology Received: 25 May 2016 / Accepted: 29 November 2016 / Published online: 16 December 2016 © Springer-Verlag Berlin Heidelberg 2016 Abstract Gleason score of 4, ≥50% positive biopsy cores (PPBC), Background Prognoses for intermediate-risk prostate can- or more than one D’Amico intermediate-risk factor (i.e., cer (PCa) remain heterogeneous. Improved substratification cT2b, PSA 10–20, or Gleason score 7). Remaining PCa could optimize treatment and monitoring strategies. The cases were classified as favorable. Main endpoints were objective was to validate this subclassification in a radical pathologic results (pT stage, final http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png World Journal of Urology Springer Journals
Loading next page...
 
/lp/springer_journal/improved-decision-making-in-intermediate-risk-prostate-cancer-a-oduTHxreCu
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2016 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Urology; Nephrology; Oncology
ISSN
0724-4983
eISSN
1433-8726
D.O.I.
10.1007/s00345-016-1979-z
Publisher site
See Article on Publisher Site

Abstract

World J Urol (2017) 35:1191–1197 DOI 10.1007/s00345-016-1979-z ORIGINAL ARTICLE Improved decision making in intermediate‑risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomy 1,3 2,3 3 1,3 Jean Baptiste Beauval · Guillaume Ploussard · Bastien Cabarrou · Mathieu Roumiguié · 4 1 6 4 5 5 Adil Ouzzane · Jérome Gas · Annabelle Goujon · Gautier Marcq · Romain Mathieu · Sébastien Vincendeau · 6 7 8 1,3 9 Xavier Cathelineau · Pierre Mongiat‑Artus · Laurent Salomon · Michel Soulié · Arnaud Méjean · 8 10 6 Alexandre de La Taille · Morgan Rouprêt · François Rozet · Committee of Cancerology of the Association of French Urology Received: 25 May 2016 / Accepted: 29 November 2016 / Published online: 16 December 2016 © Springer-Verlag Berlin Heidelberg 2016 Abstract Gleason score of 4, ≥50% positive biopsy cores (PPBC), Background Prognoses for intermediate-risk prostate can- or more than one D’Amico intermediate-risk factor (i.e., cer (PCa) remain heterogeneous. Improved substratification cT2b, PSA 10–20, or Gleason score 7). Remaining PCa could optimize treatment and monitoring strategies. The cases were classified as favorable. Main endpoints were objective was to validate this subclassification in a radical pathologic results (pT stage, final

Journal

World Journal of UrologySpringer Journals

Published: Dec 16, 2016

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off